Impact of Medical Home Implementation on Potentially Inappropriate Medication Use Among Older Adults: A Longitudinal Population-Based Study in Parma, Italy
Author(s)
Chen A1, Molaei M2, Jafari N3, Keith SW3, Alcusky M4, Lombardi M5, Pini M5, Maio V3
1Thomas Jefferson University, Flushing, NY, USA, 2Thomas Jefferson University, Bolingbrook, IL, USA, 3Thomas Jefferson University, Philadelphia, PA, USA, 4University of Massachusetts Medical School, Worcester, MA, USA, 5Local Health Authority of Parma, Parma, Italy
OBJECTIVES : Seventeen Medical Homes (MHs) were established in the Local Health Authority (LHA) of Parma, Emilia-Romagna, Italy, between 2011 and 2016. We evaluated the association between MH implementation and potentially inappropriate medication (PIM) use as a quality indicator. METHODS : We conducted a retrospective cohort study (01/01/2011-12/31/2017) using the Parma LHA administrative healthcare database. Patients were ≥ 65 years, lived in Parma for ≥1 year, had ≥1 medication dispensed, and had a documented primary care physician (PCP). PIM utilization was determined based on medications that should be always avoided in the 2011 and 2014 Maio criteria, an Italian modified version of the Beers criteria. MH exposure was determined by time-varying PCP affiliation with MHs (non-MH, pre-MH, and post-MH). Rates of PIM use were compared between exposure groups using repeated events Cox proportional hazards models and further examined based on MH complexity (high/medium or low). RESULTS : Among 129,938 older adults included, 22% of their total person-time was under exposure to MHs. Compared with non-MH patients, MH patients had higher rates of PIM use before MH opening (HR=1.06; 95% CI: 1.04-1.08) but lower rates once MHs opened (HR=0.97; 95% CI: 0.96-0.98). The MH implementation was associated with an 8% decrease in PIM (post-MH vs. pre-MH HR=0.92; 95% CI: 0.89-0.93). After MH implementation, patients in both high/medium and low complexity MHs had lower use of PIMs but the reduction was greater for those in low complexity MHs (HR=0.86; 95% CI: 0.83-0.89) than in high complexity MHs (HR=0.93; 95% CI: 0.91-0.95). CONCLUSIONS : Accounting for pre-existing differences in prescribing between MH and non-MH PCPs, the MH implementation was associated with a significant decrease in PIM use. Notably, this improvement was greater among patients in low complexity MHs. More research is needed to understand whether the reduction in PIP exposure will be sustained as MHs progress.
Conference/Value in Health Info
2021-05, ISPOR 2021, Montreal, Canada
Value in Health, Volume 24, Issue 5, S1 (May 2021)
Code
PIH21
Topic
Health Service Delivery & Process of Care
Topic Subcategory
Prescribing Behavior, Quality of Care Measurement
Disease
Geriatrics